Literature DB >> 31508571

The relationship between body mass index and preeclampsia: A systematic review and meta-analysis.

Morteza Motedayen1, Mohammad Rafiei2, Mostafa Rezaei Tavirani3, Kourosh Sayehmiri4, Majid Dousti4.   

Abstract

BACKGROUND: One of the causes of maternal and fetal mortality and morbidity is pregnancy-induced hypertension, the most common form of which is preeclampsia that causes many complications for mother and fetus.
OBJECTIVE: The aim of this systematic review and meta-analysis was to determine the relationship between body mass index (BMI) and preeclampsia in Iran.
MATERIALS AND METHODS: Using valid keywords in the SID database, PubMed, Scopus, data obtained from all the articles, which were reviewed in Iran between 2000 and 2016, were combined using the meta-analysis method (random-effects model) and analyzed using STATA version 11.1.
RESULTS: A total number of 5,946 samples were enrolled in 16 studies with the mean BMI values of 25.13, 27.42, and 26.33 kg /m 2 in the healthy, mild, and severe preeclamptic groups, respectively.
CONCLUSION: The results of this study revealed that there is a significant relationship between BMI and the risk of preeclampsia, so it can be said that BMI may be one of the ways to diagnose preeclampsia.

Entities:  

Keywords:  Body mass index; Iran; Meta-analysis.; Preeclampsia

Year:  2019        PMID: 31508571      PMCID: PMC6718883          DOI: 10.18502/ijrm.v17i7.4857

Source DB:  PubMed          Journal:  Int J Reprod Biomed        ISSN: 2476-3772


1. Introduction

Preeclampsia is a pregnancy-related disease that increases maternal and perinatal mortality and morbidity (1, 2). The possible causes of preeclampsia include abnormal vascular thromboembolic invasion, lack of maternal-fetal immune tolerance and maternal maladaptation with cardiovascular and inflammatory changes during pregnancy and genetics (3). Preeclampsia affects 5–8% of all pregnancies (4) and causes many complications for mother and fetus in such a way that 50,000 women worldwide die from preeclampsia and its complications annually (5). Researchers believe that preeclampsia is a multifactorial disease and propose several risk factors for it, including a history of preeclampsia, low and high maternal age, diabetes, chronic hypertension, null parity, birth intervals, history of abortion, high body mass index (BMI) value, twin pregnancy, fetal sex, migraine, and maternal RH (6-10). A major part of the complications and some of the risk factors proposed for this disorder can be identified and prevented. Although the termination of pregnancy is considered as a definitive treatment of preeclampsia, careful prenatal care and appropriate treatment can improve the condition, and the outcome can be satisfactory for the mother and fetus in many cases (11). Some studies have referred to obesity as a risk factor for preeclampsia and showed that the relationship between maternal weight and preeclampsia is a progressive risk and varies from 4.3% in women with a BMI 19.8 Kg/m, up to 13.3% for women with a BMI 35 kg/m (12). Since the objectives of meta-analysis include regular and systematic review of the evidence, the quantitative summing up of the results of each study, combining the results of various studies and providing a general interpretation of the results (13), the aim of the present study was to investigate the relationship between the maternal BMI and preeclampsia using the by meta-analysis technique, performing more studies in this area, and reducing neonatal morbidity and mortality.

2. Materials and Methods

The present study was carried out using the meta-analysis technique and random-effects models. It was conducted in several steps to accurately determine the problem under study and collecting, analyzing, and interpreting the findings and using preferred reporting items for systematic reviews and meta-analyses (PRISMA). The study began after using the aforementioned protocol as a research criterion as well as identifying the members of the meta-analysis group (including the group's supervisor and the final reviewer, the group's advisor, reviewer, and researcher; data extractor and collector; and article explorer). To review the studies, SID, Scopus, and PubMed databases were first systematically searched using valid Persian keywords (preeclampsia, BMI, pregnancy) and valid English keywords (preeclampsia, BMI, and pregnancy) in order to identify and evaluate the studies on the prevalence of preeclampsia in pregnant women in Iran. The studies were later classified as case-controls.

Selection of studies and data extraction

All articles related to preeclampsia were collected and a list of articles' abstract was later prepared after the completion of the search. Then all articles, in which the BMI value was specified, were included in the first list. Then, quality assessment was done by the Newcastle-Ottawa Scale. The adjusted Ottawa checklist was used to evaluate the quality of the studies. In this case, three subsets of the groups (four questions), group comparability (one question), and exposure or outcome (two questions) are examined (14), this tool is usually used for Validity assessment and is a reliable instrument with a long history of reliability (15). Studies with a score of 3 or more were considered qualitative and entered into the analysis. Other studies that addressed preeclampsia, causes of preeclampsia, ways to cope with preeclampsia, and risk factors for preeclampsia in pregnant women were excluded from the list. A necessary information checklist containing the researcher's name, article's title, year of conducting the research, research setting, code of the research setting, age group, sample size, BMI, etc., were prepared for all studies that underwent the initial evaluation in order to undergo the final evaluation. Finally, the final checklist was reviewed and the relevant articles were entered into the meta-analysis. According to these steps, 101 articles were found using the keywords in the first search. After the analysis phase, 16 appropriate articles entered the meta-analysis phase (Figure 1, Table I). Specifications of the studies performed Flowchart of the stages of the systematic review and meta-analysis.

Inclusion and exclusion criteria

Inclusion criteria included access to the full text of the article, English or Persian, articles aimed at examining the relationship between the components studied. Exclusion Criteria included unrelated articles, the inaccessibility of the full text of the article, and the incomplete abstract of the article. All analyzes were performed in this study using STATA according to the critical evaluation criteria and the eligible articles were included in the study.

Statistical analysis

Considering that the main index studied in this review study was BMI, its variance was calculated by the binomial distribution, and the odd ratio with a 95% confidence interval (CI) was calculated. The weighted average was used to combine the rates obtained from different studies. Each study was weighted inversely in proportion to its variance. The heterogeneity was evaluated using Q test and I2 at the given significance level (α 10%). Data analysis was performed using the meta-analysis technique (random-effects model) in cases of any heterogeneity. Data analysis was carried out using R and STATA Version 11.2.

3. Results

In the present study, a total of 16 articles which were published between 2000 and 2016 were reviewed and the total sample size was 5,946 women. The mean BMI was 25.13 (95% CI: 23.52-2.74) (Figure 2), 27.42 kg (95% CI: 24.4-30.34), (Figure 3), and 26.33 kg/m (95% CI: 24.52-28.13) (Figure 4) in the healthy, mild, and severe PE groups, respectively. As seen in Table II, the mean maternal age in the healthy and affected groups was 26.21 and 28.20 years, respectively, which indicates the effect of age on the disorder, considering the studied variable (BMI); however, this relationship was not significant. Also, the mean systolic and diastolic blood pressure was 142.75, 99.26 and 101.59, 70.76 mmHg in the affected and healthy groups, respectively, which indicates a direct relationship between hypertension and preeclampsia. These results revealed that hypertension is somewhat associated with an increase in BMI. Also, the average week of pregnancy in the healthy and affected mothers is 34.15 and 33.82 weeks, respectively, which seems to indicate no specific relationship between individuals with preeclampsia and BMI with the average week of pregnancy. According to the publication bias figure, Beggs test showed that the effect of bias in these studies was significant. (p = 0.584) (Figure 5). The mean of variables in the studies BMI in healthy pregnant women, by year, prevalence rate, and 95% CI interval. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI. The BMI value in pregnant women with mild PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI. The BMI value in pregnant with severe PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI length. The diamond sign indicates the result of combining all studies at 95% CI. Beggs Funnel plot for publication bias.

4. Discussion

In this study, the average age of the mothers was 21.26 years in the healthy group and 20.28 years in the affected mothers. The average height of mothers was 159.14 cm in the healthy group and 159.19 cm in the affected group. Finally, the mean value of BMI was 25.13% in the healthy group and 26.33% in the (severely) affected group. The highest BMI in the healthy pregnant women was 29.14% and the lowest one was 21.95%. Furthermore, the highest BMI in the pregnant women with preeclampsia was 30.35% and the lowest was 22.39%. Moreover, in this study, the general prevalence of preeclampsia (severe) was 7% and the general prevalence of preeclampsia (mild) was obtained as 23%. The mean systolic hypertension in the studied group was 142.75 mmHg, while that of the healthy group was 101.59 mmHg, and the mean diastolic hypertension was 99.26 mmHg in the affected group and 70.76 mmHg in the healthy mothers. According to the results obtained earlier, it can be concluded that the relationship between age and the incidence of intended disorder considering BMI was not significant. Further, there is no specific relationship between those with preeclampsia and BMI with the mean of gestational age. Hypertension has a direct relationship with preeclampsia. According to these results, it can be concluded that hypertension is one of the factors that increases BMI in pregnant women. Additionally, high BMI has a relationship with preeclampsia in pregnant women. This result is relatively consistent with Brown's study; in the Brown's study, the percentage of preeclampsia prevalence (4.5%) in women with light weight is approximately half of the women with normal weight (0.09) (31). In a study by Vahid Roodsari et al. BMI was reported to be 24 kg/m in the pre-pregnancy control group, 26.124 kg/m in the gestational hypertension group, 26.24 kg/m in the group with mild preeclampsia and 26.24 kg/m in the severe preeclampsia group. It has been reported (32), according to the obtained results, that if weight increases before pregnancy, weight loss will prevent mortality during pregnancy. Jang et al. in Seoul, Korea, compared two groups and showed that the incidence of preeclampsia in women with overweight women is higher than those of normal weight (33). Derif et al. also stated that hypertension problems occurs more in overweight women indicating its incidence 7% to 17% (34). Kramer, in a researcher at the University of New York, found that as the BMI increases among the mothers, the risk of cesarean operation will increase significantly (35). In the study by Ohkuchi et al. the incidence of hypertension during pregnancy in women with less weight, normal weight, weight more than normal, and obese was 1.1%, 1.8%, 5.8%, and 19.6%, respectively, which besides its consistency with the results of this study, indicates that the incidence of pre-pregnancy hypertension in obese women significantly increases (36). Sibai also reported in a study that high weight before pregnancy is an important risk factor for pregnancy toxicity (37). These results are relatively consistent with the conducted study. In addition, in a study by Bondar in the United States, it was shown that 56% of women with gestational toxicity were suffering from either overweight or obesity, and every 4-unit increase in BMI was related to twice the risk of gestational toxicity and an 8-unit increase in BMI was related to three times the risk of gestational toxicity (38). In another study by Belogolovkin et al. in the United States, it was concluded that the probability of a pregnancy-related hypertention in women with a high BMI (26.1-29 kg/m) was 6%, whereas in women with a normal BMI (19.86-26 kg/m) it was 3.2%, and the probability of pregnancy toxicity in women with normal BMI is 1.9%, whilein women with a high BMI, it was 2.8% (39). Cogswell and Yip, in the United States, showed that women with high BMI have more deliveries (40). In the conducted study also women with heavy weight had more deliveries. Naevy et al., found that the prenatal mortality was higher in women with heavy weight than other groups, and it is said that the reason behind it lies in the increased multiple pregnancy and preterm birth (41). Women with high BMI have adverse effects of pregnancy, delivery, and neonate, and even in the pre-pregnancy period; women with abnormal weight face with problems such as polycystic ovary, infertility, and failure in infertility treatments (41). Pregnant women with abnormal weight and obesity are subject to the risk of diabetes mellitus type 2, gestational diabetes, and preeclampsia (42), thromboembolic diseases (43), dyspnea (44), asthma (45), cholecystitis (46), back pain, pelvic pain (47) and urinary incontinence (48).

Problems regarding data extraction

Among the problems we encountered during the data extraction in this article were the irrelevancy of the article to the stated subject, the inaccessibility of the full text of the article, and the incomplete information given in the abstract part of the article. The control of all discomfit factors was not possible, and factors such as diet are effective factors that have not been measured in studies.

5. Conclusion

This meta-analysis study, in which BMI was evaluated, showed that the risk of preeclampsia may increase with an increase in BMI. Therefore, BMI can be considered as one of the ways to diagnose the preeclampsia.

Conflict of Interest

The authors declare that there is no conflict of interest.
Table 1

Specifications of the studies performed


Researcher Year of study implementation Sample size Type of study Average age group of participants BMI in healthy group 95% CI (BMI in the healthy group) BMI in mild PE group 95% CI (BMI in the mildly affected group) BMI in the severe affected group 95% CI (BMI in the severe affected group)
162007200Case-control26.882423.17–24.732625.72–26.282624.86–27.14
172012498Case-control29.0125.9125.27–26.5528.9927.63–30.3526.2925.31–27.27
182007400Case-control23.1926.2425.97–26.5129.9328.21–31.65
192012112Case-control24.9423.6022.68–24.5222.3920.43–24.35
202010675Case-control32.8521.0521.15
212006636Case-control2723
222010610Case-control22.8520
23201390Case-control27.325.3024.57–26.0325.9025.02–26.78
242009187Case-control25.8123.2523.01–23.4923.4723.19–23.75
25200864Case-control26.3729.1428.96–29.3230.3530.14–30.56
26201060Case-control31.6721.9521.77–22.1323.6523.38–23.92
272001674Case-control24.424.2023.61–24.792423.61–24.39
28201060Case-control31.5126.7426.59–26.8927.6127.44–27.78
29200680Case-control23.712.4112.61
3020101200Case-control28.1125.4528.56
BMI: Body mass index
Table 2

The mean of variables in the studies


Variables Number of study 95% confidence interval
Healthy group1326.21 (24.04-28.38)
Mean age of pregnant mothersAffected group228.20 (26.61-29.80)
Healthy mothers5101.59 (96.60-106.58)
Mean systolic blood pressureAffected mothers5142.75 (132.12-153.38)
Healthy mothers770.76 (65.87-75.65)
Mean diastolic blood pressureAffected mothers799.26 (91.74-106.79)
Healthy mothers834.15 (37.16-31.15)
Mean week of pregnancyAffected mothers833.82 (30.67-36.96)
Healthy mothers2159.14 (157.04-161.24)
Mean maternal height (in cm)Affected mothers2159.19 (157.90-160.47)
Healthy mothers23094.39 (2837.84-3350.92)
Mean maternal weight (gr)Affected mothers22508 (1903.35-3113.83)
Healthy mothers1125.13 (23.52-26.74)
Affected mothers (mild)227.42 (24.49-30.34)
<brow>-3</erow> Mean BMIAffected mothers (severe)1126.33 (24.52-28.13)
Healthy mothers834 (31-37)
Mean pregnancy weekAffected mothers833 (30-37)
Healthy mothers5101.50 (96.6-106.58)
Mean blood pressure systolicAffected mothers5147.75 (132.12-153.38)
Healthy mothers756.24 (32.36-80.12)
Mean blood pressure diastolic 8Affected mothers781.49 (64.03-98.95)
  37 in total

1.  Maternal body mass index and the risk of preeclampsia: a systematic overview.

Authors:  Tara E O'Brien; Joel G Ray; Wee-Shian Chan
Journal:  Epidemiology       Date:  2003-05       Impact factor: 4.822

2.  The effect of low body mass index on the development of gestational hypertension and preeclampsia.

Authors:  Victoria Belogolovkin; Keith A Eddleman; Fergal D Malone; Lisa Sullivan; Robert H Ball; David A Nyberg; Christine H Comstock; Gary D V Hankins; Suzanne Carter; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Mary E D'Alton
Journal:  J Matern Fetal Neonatal Med       Date:  2007-07

3.  Early pregnancy waist-to-hip ratio and risk of preeclampsia: a prospective cohort study.

Authors:  Mahboubeh Taebi; Zohreh Sadat; Farzaneh Saberi; Masoumeh Abedzadeh Kalahroudi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

Review 4.  Pre-eclampsia: Risk factors and causal models.

Authors:  Lill Trogstad; Per Magnus; Camilla Stoltenberg
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-02-23       Impact factor: 5.237

5.  Management of preeclampsia.

Authors:  Gustaaf Albert Dekker
Journal:  Pregnancy Hypertens       Date:  2014-07-09       Impact factor: 2.899

6.  The relationship between headache and preeclampsia: a case-control study.

Authors:  F Facchinetti; G Allais; R D'Amico; C Benedetto; A Volpe
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-08-01       Impact factor: 2.435

Review 7.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

Review 8.  The influence of fetal and maternal factors on the distribution of birthweight.

Authors:  M E Cogswell; R Yip
Journal:  Semin Perinatol       Date:  1995-06       Impact factor: 3.300

9.  Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  B M Sibai; T Gordon; E Thom; S N Caritis; M Klebanoff; D McNellis; R H Paul
Journal:  Am J Obstet Gynecol       Date:  1995-02       Impact factor: 8.661

Review 10.  Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review.

Authors:  Raúl Herzog; María José Álvarez-Pasquin; Camino Díaz; José Luis Del Barrio; José Manuel Estrada; Ángel Gil
Journal:  BMC Public Health       Date:  2013-02-19       Impact factor: 3.295

View more
  3 in total

1.  Immunometabolic adaptation and immune plasticity in pregnancy and the bi-directional effects of obesity.

Authors:  April Rees; Oliver Richards; Megan Chambers; Benjamin J Jenkins; James G Cronin; Catherine A Thornton
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

2.  Role of Periodontal Bacteria, Viruses, and Placental mir155 in Chronic Periodontitis and Preeclampsia-A Genetic Microbiological Study.

Authors:  Jaideep Mahendra; Little Mahendra; Maryam H Mugri; Mohammed E Sayed; Shilpa Bhandi; Rahaf Turki Alshahrani; Thodur Madapusi Balaji; Saranya Varadarajan; Swetha Tanneeru; Abirami Nayaki Rao P; Sruthi Srinivasan; Rodolfo Reda; Luca Testarelli; Shankargouda Patil
Journal:  Curr Issues Mol Biol       Date:  2021-07-29       Impact factor: 2.976

3.  Erythropoietin Mimetic Peptide (pHBSP) Corrects Endothelial Dysfunction in a Rat Model of Preeclampsia.

Authors:  Mikhail Korokin; Vladimir Gureev; Oleg Gudyrev; Ivan Golubev; Liliya Korokina; Anna Peresypkina; Tatiana Pokrovskaia; Galina Lazareva; Vladislav Soldatov; Mariya Zatolokina; Anna Pobeda; Elena Avdeeva; Evgeniya Beskhmelnitsyna; Tatyana Denisyuk; Natalia Avdeeva; Olga Bushueva; Mikhail Pokrovskii
Journal:  Int J Mol Sci       Date:  2020-09-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.